Chinese herbal medicine and prednisone increase proportion of splenic CD4+CD25-FOXP3+ cells and alleviate glomerular lesion in MRL/LPRmice
Objective: This study investigated the effects of Chinese herbal medicine and prednisone onCD4+FoxP3+ T cells (Tregs) and Th17 cells in the MRL/lpr mouse model of systemic lupus erythematosus.
Methods: MRL/lpr mice were treated with herbal medicine (yin-nourishing and heat-clearing therapy), prednisone, and a combination of both for 7 weeks. The proportions of CD4+CD25-FOXP3+ cells, CD4+CD25-FOXP3+ cells, and CD4+IL-17+ cells in splenic mononuclear cell suspension were determined by flow cytometry. Histological slices of kidneys were stained by H&E, PAS, and Masson’s method. Activity indexes (AI) of glomerular lesions were scored.
Results: The result showed that both herbal medicine and prednisone significantly increased the proportion of CD4+CD25-FOXP3+ cells (P<0.05), but lowered the proportion of CD4+CD25-FOXP3+ cells (P<0.05) and CD4+IL-17+ cells (P<0.05) in MRL/lpr mice. Consequently, CD4+CD25-FOXP3+ cells became dominant CD4+ FoxP3+ cells after either treatment. AIl the glomerular lesions in both herbal medicine group and prednisone group were significantly lower than those in the model group (P<0.05). AI was positively related with the proportion of CD4+IL-17+ cells (Spearman's rho= 0.4958, P＜0.05), but was negatively correlated with the proportions of CD4+Foxp3+ cells(Spearman's rho= -0.5934，P＜0.05) and CD4+CD25-FOXP3+ cells (Spearman's rho= -0.5914，P＜0.05).
Conclusion: Both Chinese herbal medicine and prednisone significantly enhanced the proportion of CD4+CD25-FOXP3+ cells and reduced the proportion of Th17 cells in lupus-prone MRL/lpr mice. Increased proportion of CD4+CD25-FOXP3+ cells was correlated with less severe glomerular lesions, indicating that CD4+CD25-FOXP3+ cells might play a regulatory role in the treatment of systemic lupus erythematosus.
Keywords: Systemic lupus erythematosus; regulatory T cells; Herbal medicine; Prednisone
Copyright: Creative Commons Attribution CC.
This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. View License Deed | View Legal Code Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications.